Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Go Vida Plena

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Go Vida Plena head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 238 · Grade C

Go Vida Plena

Visit Go Vida Plena Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Go Vida Plena a bad call — it's best for readers comparing oral and injectable plans who can confirm the full prepaid charge and the refund cutoff. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
73
Transparency
90
72
Access Breadth
93
56
Clinical Oversight
92
88
Track Record
88
63
CoreAge RxBrief Score 94 · 66Go Vida Plena

Price, coverage & the tracker

CoreAge RxGo Vida Plena
Brief Score94/100 (A)66/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Injection $269 · oral $299

Shortest listed one-time options. Injection regular price $299.

12, 24 or 48 weeks are paid upfront at different totals.

Full price details

Compounded semaglutide offered; complete selected-plan quote unknown; $269 listed for the shortest injectable plan ($299 regular), $299 for the shortest oral plan; prepaid 12-, 24- and 48-week terms are separate

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Injection $359 · oral $349

Shortest listed one-time options. Injection regular price $399.

12, 24 or 48 weeks are paid upfront at different totals.

Full price details

Compounded tirzepatide offered; complete selected-plan quote unknown; $359 listed for the shortest injectable plan ($399 regular), $349 for the shortest oral plan; prepaid 12-, 24- and 48-week terms are separate

CoverageUS only; restrictions by state, confirmed at intakeConfirm availability for your location and the dispensing pharmacy.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Go Vida Plena: Go Vida Plena lists four compounded options and one-time payments. Compare the full supply and ask what qualifies for a refund before prepaying.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.